vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and SouthState Bank Corp (SSB). Click either name above to swap in a different company.
SouthState Bank Corp is the larger business by last-quarter revenue ($661.7M vs $617.8M, roughly 1.1× Hims & Hers Health, Inc.). SouthState Bank Corp runs the higher net margin — 34.1% vs 3.3%, a 30.8% gap on every dollar of revenue. Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 37.4%).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
SouthState Bank, based in Winter Haven, Florida, is an American bank and a subsidiary of SouthState Corporation, a bank holding company. As of May 26, 2025, the company had 371 branches in South Carolina, North Carolina, Georgia, Florida, Alabama, Virginia, Colorado and Texas.
HIMS vs SSB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $617.8M | $661.7M |
| Net Profit | $20.6M | $225.8M |
| Gross Margin | 71.9% | — |
| Operating Margin | 1.5% | 15.1% |
| Net Margin | 3.3% | 34.1% |
| Revenue YoY | 28.4% | — |
| Net Profit YoY | -20.8% | 153.5% |
| EPS (diluted) | $0.08 | $2.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $661.7M | ||
| Q4 25 | $617.8M | $581.1M | ||
| Q3 25 | $599.0M | $599.7M | ||
| Q2 25 | $544.8M | $577.9M | ||
| Q1 25 | $586.0M | $544.5M | ||
| Q4 24 | $481.1M | $369.8M | ||
| Q3 24 | $401.6M | $351.5M | ||
| Q2 24 | $315.6M | $350.3M |
| Q1 26 | — | $225.8M | ||
| Q4 25 | $20.6M | $247.7M | ||
| Q3 25 | $15.8M | $246.6M | ||
| Q2 25 | $42.5M | $215.2M | ||
| Q1 25 | $49.5M | $89.1M | ||
| Q4 24 | $26.0M | $144.2M | ||
| Q3 24 | $75.6M | $143.2M | ||
| Q2 24 | $13.3M | $132.4M |
| Q1 26 | — | — | ||
| Q4 25 | 71.9% | — | ||
| Q3 25 | 73.8% | — | ||
| Q2 25 | 76.4% | — | ||
| Q1 25 | 73.5% | — | ||
| Q4 24 | 76.8% | — | ||
| Q3 24 | 79.2% | — | ||
| Q2 24 | 81.3% | — |
| Q1 26 | — | 15.1% | ||
| Q4 25 | 1.5% | 54.3% | ||
| Q3 25 | 2.0% | 53.6% | ||
| Q2 25 | 4.9% | 48.8% | ||
| Q1 25 | 9.9% | 22.3% | ||
| Q4 24 | 3.9% | 50.7% | ||
| Q3 24 | 5.6% | 53.1% | ||
| Q2 24 | 3.5% | 49.3% |
| Q1 26 | — | 34.1% | ||
| Q4 25 | 3.3% | 42.6% | ||
| Q3 25 | 2.6% | 41.1% | ||
| Q2 25 | 7.8% | 37.2% | ||
| Q1 25 | 8.4% | 16.4% | ||
| Q4 24 | 5.4% | 39.0% | ||
| Q3 24 | 18.8% | 40.7% | ||
| Q2 24 | 4.2% | 37.8% |
| Q1 26 | — | $2.28 | ||
| Q4 25 | $0.08 | $2.47 | ||
| Q3 25 | $0.06 | $2.42 | ||
| Q2 25 | $0.17 | $2.11 | ||
| Q1 25 | $0.20 | $0.87 | ||
| Q4 24 | $0.10 | $1.88 | ||
| Q3 24 | $0.32 | $1.86 | ||
| Q2 24 | $0.06 | $1.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.6M | $2.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $540.9M | $9.0B |
| Total Assets | $2.2B | $68.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.9B | ||
| Q4 25 | $228.6M | — | ||
| Q3 25 | $345.8M | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $273.7M | — | ||
| Q4 24 | $220.6M | — | ||
| Q3 24 | $165.5M | — | ||
| Q2 24 | $129.3M | — |
| Q1 26 | — | $9.0B | ||
| Q4 25 | $540.9M | $9.1B | ||
| Q3 25 | $581.0M | $9.0B | ||
| Q2 25 | $562.7M | $8.8B | ||
| Q1 25 | $549.3M | $8.6B | ||
| Q4 24 | $476.7M | $5.9B | ||
| Q3 24 | $440.1M | $5.9B | ||
| Q2 24 | $362.0M | $5.7B |
| Q1 26 | — | $68.0B | ||
| Q4 25 | $2.2B | $67.2B | ||
| Q3 25 | $2.2B | $66.0B | ||
| Q2 25 | $1.9B | $65.9B | ||
| Q1 25 | $891.7M | $65.1B | ||
| Q4 24 | $707.5M | $46.4B | ||
| Q3 24 | $602.3M | $46.1B | ||
| Q2 24 | $480.5M | $45.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.3M | — |
| Free Cash FlowOCF − Capex | $-2.5M | — |
| FCF MarginFCF / Revenue | -0.4% | — |
| Capex IntensityCapex / Revenue | 10.3% | — |
| Cash ConversionOCF / Net Profit | 2.98× | — |
| TTM Free Cash FlowTrailing 4 quarters | $57.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $61.3M | $232.1M | ||
| Q3 25 | $148.7M | $122.4M | ||
| Q2 25 | $-19.1M | $72.6M | ||
| Q1 25 | $109.1M | $-126.3M | ||
| Q4 24 | $86.4M | $354.3M | ||
| Q3 24 | $85.3M | $-246.8M | ||
| Q2 24 | $53.6M | $126.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-2.5M | $215.5M | ||
| Q3 25 | $79.3M | $101.7M | ||
| Q2 25 | $-69.5M | $52.5M | ||
| Q1 25 | $50.1M | $-139.1M | ||
| Q4 24 | $59.5M | $340.9M | ||
| Q3 24 | $79.4M | $-254.2M | ||
| Q2 24 | $47.6M | $117.3M |
| Q1 26 | — | — | ||
| Q4 25 | -0.4% | 37.1% | ||
| Q3 25 | 13.2% | 17.0% | ||
| Q2 25 | -12.8% | 9.1% | ||
| Q1 25 | 8.5% | -25.5% | ||
| Q4 24 | 12.4% | 92.2% | ||
| Q3 24 | 19.8% | -72.3% | ||
| Q2 24 | 15.1% | 33.5% |
| Q1 26 | — | — | ||
| Q4 25 | 10.3% | 2.9% | ||
| Q3 25 | 11.6% | 3.5% | ||
| Q2 25 | 9.3% | 3.5% | ||
| Q1 25 | 10.1% | 2.4% | ||
| Q4 24 | 5.6% | 3.6% | ||
| Q3 24 | 1.5% | 2.1% | ||
| Q2 24 | 1.9% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 2.98× | 0.94× | ||
| Q3 25 | 9.43× | 0.50× | ||
| Q2 25 | -0.45× | 0.34× | ||
| Q1 25 | 2.20× | -1.42× | ||
| Q4 24 | 3.32× | 2.46× | ||
| Q3 24 | 1.13× | -1.72× | ||
| Q2 24 | 4.03× | 0.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HIMS
Segment breakdown not available.
SSB
| Net Interest Income | $561.6M | 85% |
| Noninterest Income | $100.1M | 15% |
